Skip to content

US · GRCE

Grace Therapeutics, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Princeton, NJ 08540

Price · as of 2026-09-04

$2.10

Market cap 34.83M

Price history

Weekly OHLC price history for GRCE, USD per share
WeekOpenHighLowCloseVolume
Sep 30, 2024 – Oct 4, 2024$3.01$3.12$2.77$3.110
Oct 7, 2024 – Oct 11, 2024$3.11$3.50$3.02$3.340
Oct 14, 2024 – Oct 18, 2024$3.37$3.44$3.21$3.330
Oct 21, 2024 – Oct 25, 2024$3.27$3.60$3.12$3.370
Oct 28, 2024 – Nov 1, 2024$3.04$3.32$2.95$3.100
Nov 4, 2024 – Nov 8, 2024$3.10$3.26$2.88$2.950
Nov 11, 2024 – Nov 15, 2024$3.00$3.46$2.95$3.110
Nov 18, 2024 – Nov 22, 2024$3.10$3.49$3.01$3.280
Nov 25, 2024 – Nov 29, 2024$3.26$3.45$3.26$3.360
Dec 2, 2024 – Dec 6, 2024$3.25$4.97$3.22$4.500
Dec 9, 2024 – Dec 13, 2024$4.40$4.46$3.52$3.580
Dec 16, 2024 – Dec 20, 2024$3.57$4.18$3.57$3.820
Dec 23, 2024 – Dec 27, 2024$3.99$3.99$3.37$3.710
Dec 30, 2024 – Jan 3, 2025$3.63$4.19$3.57$4.000
Jan 6, 2025 – Jan 10, 2025$4.09$4.68$4.04$4.190
Jan 13, 2025 – Jan 17, 2025$4.49$4.49$3.30$3.660
Jan 20, 2025 – Jan 24, 2025$3.84$4.00$3.56$3.900
Jan 27, 2025 – Jan 31, 2025$3.83$3.90$2.95$3.300
Feb 3, 2025 – Feb 7, 2025$3.33$3.55$3.06$3.240
Feb 10, 2025 – Feb 14, 2025$3.29$3.71$2.90$3.450
Feb 17, 2025 – Feb 21, 2025$3.47$3.52$3.23$3.290
Feb 24, 2025 – Feb 28, 2025$3.25$3.29$2.80$3.030
Mar 3, 2025 – Mar 7, 2025$2.97$2.97$2.40$2.540
Mar 10, 2025 – Mar 14, 2025$2.54$2.54$2.07$2.180
Mar 17, 2025 – Mar 21, 2025$2.21$2.65$2.16$2.550
Mar 24, 2025 – Mar 28, 2025$2.53$2.69$2.26$2.320
Mar 31, 2025 – Apr 4, 2025$2.31$2.40$1.98$2.000
Apr 7, 2025 – Apr 11, 2025$1.94$2.14$1.75$1.980
Apr 14, 2025 – Apr 17, 2025$1.98$2.20$1.98$2.090
Apr 21, 2025 – Apr 25, 2025$2.01$2.49$2.01$2.490
Apr 28, 2025 – May 2, 2025$2.43$3.09$2.37$3.040
May 5, 2025 – May 9, 2025$3.14$3.14$2.71$2.720
May 12, 2025 – May 16, 2025$2.79$2.80$2.60$2.800
May 19, 2025 – May 23, 2025$2.80$3.08$2.80$2.970
May 26, 2025 – May 30, 2025$3.04$3.04$2.77$2.770
Jun 2, 2025 – Jun 6, 2025$2.77$3.00$2.76$2.970
Jun 9, 2025 – Jun 13, 2025$2.95$3.30$2.80$2.840
Jun 16, 2025 – Jun 20, 2025$2.91$3.10$2.83$3.000
Jun 23, 2025 – Jun 27, 2025$3.00$3.10$2.90$2.970
Jun 30, 2025 – Jul 3, 2025$2.91$3.17$2.91$3.130
Jul 7, 2025 – Jul 11, 2025$3.04$3.50$2.97$3.450
Jul 14, 2025 – Jul 18, 2025$3.43$3.74$3.10$3.360
Jul 21, 2025 – Jul 25, 2025$3.30$3.49$3.05$3.080
Jul 28, 2025 – Aug 1, 2025$3.08$3.14$2.81$2.870
Aug 4, 2025 – Aug 8, 2025$2.95$3.37$2.80$3.220
Aug 11, 2025 – Aug 15, 2025$3.28$3.40$2.93$3.260
Aug 18, 2025 – Aug 22, 2025$3.28$3.40$3.17$3.250
Aug 25, 2025 – Aug 29, 2025$3.26$3.39$2.91$3.030
Sep 1, 2025 – Sep 5, 2025$2.99$3.30$2.93$3.200
Sep 8, 2025 – Sep 12, 2025$3.22$3.34$3.07$3.150
Sep 15, 2025 – Sep 19, 2025$3.10$3.18$3.04$3.100
Sep 22, 2025 – Sep 26, 2025$3.12$3.14$3.01$3.090
Sep 29, 2025 – Oct 3, 2025$3.10$3.10$2.91$3.030
Oct 6, 2025 – Oct 10, 2025$3.00$3.09$2.96$2.990
Oct 13, 2025 – Oct 17, 2025$2.98$3.31$2.95$3.120
Oct 20, 2025 – Oct 24, 2025$3.11$3.40$3.07$3.140
Oct 27, 2025 – Oct 31, 2025$3.14$3.25$3.10$3.160
Nov 3, 2025 – Nov 7, 2025$3.11$3.16$2.95$2.990
Nov 10, 2025 – Nov 14, 2025$3.01$3.14$2.98$3.060
Nov 17, 2025 – Nov 21, 2025$3.06$3.29$3.00$3.190
Nov 24, 2025 – Nov 28, 2025$3.17$3.27$3.11$3.180
Dec 1, 2025 – Dec 5, 2025$3.17$3.28$3.08$3.220
Dec 8, 2025 – Dec 12, 2025$3.22$3.54$3.21$3.310
Dec 15, 2025 – Dec 19, 2025$3.30$3.48$3.24$3.400
Dec 22, 2025 – Dec 26, 2025$3.38$3.67$3.34$3.400
Dec 29, 2025 – Jan 2, 2026$3.40$3.69$3.36$3.660
Jan 5, 2026 – Jan 9, 2026$3.67$3.92$3.48$3.690
Jan 12, 2026 – Jan 16, 2026$3.68$3.81$3.50$3.650
Jan 19, 2026 – Jan 23, 2026$3.40$3.94$3.40$3.820
Jan 26, 2026 – Jan 30, 2026$3.83$3.90$3.45$3.630
Feb 2, 2026 – Feb 6, 2026$3.58$3.83$3.45$3.600
Feb 9, 2026 – Feb 13, 2026$3.59$3.75$3.48$3.610
Feb 16, 2026 – Feb 20, 2026$3.65$4.10$3.64$3.880
Feb 23, 2026 – Feb 27, 2026$3.88$4.30$3.88$4.290
Mar 2, 2026 – Mar 6, 2026$4.25$4.29$3.58$3.860
Mar 9, 2026 – Mar 13, 2026$3.76$4.65$3.76$4.200
Mar 16, 2026 – Mar 20, 2026$4.22$4.71$4.16$4.420
Mar 23, 2026 – Mar 27, 2026$4.50$4.94$4.33$4.670
Mar 30, 2026 – Apr 2, 2026$4.68$5.18$4.32$5.130
Apr 6, 2026 – Apr 10, 2026$5.10$5.11$2.50$3.590
Apr 13, 2026 – Apr 17, 2026$3.48$4.98$3.48$4.600
Apr 20, 2026 – Apr 24, 2026$4.75$5.06$1.79$2.300
Apr 27, 2026 – May 1, 2026$2.33$2.49$2.03$2.340
May 4, 2026 – May 8, 2026$2.35$2.56$2.21$2.340
May 11, 2026 – May 15, 2026$2.32$2.45$2.11$2.160
May 18, 2026 – May 22, 2026$2.13$2.30$2.08$2.200
May 25, 2026 – May 29, 2026$2.21$2.60$2.21$2.570
Jun 1, 2026 – Jun 5, 2026$2.52$2.71$2.26$2.300
Jun 8, 2026 – Jun 12, 2026$2.30$2.40$2.16$2.200
Jun 15, 2026 – Jun 18, 2026$2.20$2.38$2.13$2.380
Jun 22, 2026 – Jun 26, 2026$2.30$2.48$2.24$2.380
Jun 29, 2026 – Jul 2, 2026$2.35$2.44$2.08$2.370
Jul 6, 2026 – Jul 10, 2026$2.35$2.58$2.35$2.450
Jul 13, 2026 – Jul 17, 2026$2.50$2.54$2.33$2.470
Jul 20, 2026 – Jul 24, 2026$2.44$2.48$2.29$2.330
Jul 27, 2026 – Jul 31, 2026$2.30$2.44$1.85$2.080
Aug 3, 2026 – Aug 7, 2026$2.13$2.25$2.07$2.130
Aug 10, 2026 – Aug 14, 2026$2.13$2.19$2.02$2.160
Aug 17, 2026 – Aug 21, 2026$2.19$2.25$2.04$2.200
Aug 24, 2026 – Aug 28, 2026$2.23$2.23$2.10$2.120
Aug 31, 2026 – Sep 4, 2026$2.10$2.20$2.07$2.100

Valuation

MetricValueUpside
IC Value
P/E-4.87
P/B0.59
P/S
EV/EBITDA-1.90
PEG
P/TBV2.60

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for GRCE, USD per share
YearPriceAIICGraham-DoddGraham Formula
2012$1,152.00
2013$1,209.60
2014$456.00$199.06
2015$196.80$247.96
2016$64.32$539.60
2017$60.96
2018$33.12
2019$42.72
2020$36.00
2021$26.40
2022$6.00
2023$2.94
2024$3.06
2025$2.97
2026$2.30

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Grace Therapeutics, Inc.

        Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.

        CEO
        Prashant Kohli
        Employees
        5
        Beta
        0.37

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for GRCE: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        GRCEGrace Therapeutics, Inc.$2.1334.83M-4.870.59-1.902.600.00%0.00%0.00%-11.94%-19.90%-11.24%0.008.107.921.53-58.41%-40.49%-23.36%-4.13-19.41%0.00%0.00%0.00%-1.90-2.373.19
        ABVCABVC BioPharma, Inc.$1.0114.64M$9,273.20+918,039%-3.532.66-4.342.660.00%0.00%0.00%-135.79%-82.48%-58.58%0.31-17.200.410.24-0.38-7.14%-100.00%65.07%-10.11%-0.48-34.44%0.00%0.00%0.00%-4.51-10.80-4.16
        CALCCalciMedica, Inc.$0.7411.67M-421.47-1876.13-443.37-685.59-1876.130.00%0.00%0.00%-761.02%325.28%-177.10%-1.46-16.263.583.440.0661.48%0.25%-0.17%-5.60298.34%0.00%0.00%0.00%-538.73-587.38345.24
        LTRNLantern Pharma Inc.$2.8035.73M-1.523.99-5.523.990.00%0.00%0.00%-123.51%-49.68%-93.53%12.022.402.25-4.33-99.92%-12.04%-60.20%-3.48-43.33%0.00%0.00%0.00%-5.25-6.03-13.04
        OKUROnKure Therapeutics, Inc.$4.1656.88M-0.860.910.13-7.530.910.00%0.00%0.00%-74.39%1541.95%-67.24%0.0110.289.971.0011.39%1.38%-101.53%-8.751270.64%0.00%0.00%0.00%0.120.14-1.95
        PDSBPDS Biotechnology Corpora…$0.7340.64M0.003.16-0.643.160.00%0.00%0.00%-244158.22%4384.86%-90953.88%1.83-5.912.982.820.32-28.16%79057.52%-94818.77%-2926.443988570.09%0.00%0.00%0.00%-0.620.00-11.79
        RNXTRenovoRx, Inc.$1.0639.46M$180.75+16,952%-2.645.4426.27-2.035.4470.88%-1113.98%-994.48%-225.62%660.51%-137.77%0.044.023.650.61-13.51%2511.63%20.12%-37.20%-5.59579.46%0.00%0.00%0.00%-1.81-2.0720.21-8.08
        TVRDTvardi Therapeutics, Inc.$2.0018.76M$5.90+195%-1.601.390.081.410.00%0.00%0.00%-222.76%693.67%-47.99%0.012.862.791.13-93.00%-100.00%-62.08%-80.80%-2.13609.41%0.00%0.00%93.11%0.060.06-5.24
        XLOXilio Therapeutics, Inc.$9.1159.9M$52.26+474%-17.0416.9213.64-13.9216.9296.48%-95.92%-80.05%-132.53%67.25%-31.04%0.202.582.533.90-72.54%589.88%-70.08%-0.92%-0.098.83%0.00%0.00%13.98%-11.11-84.6210.65-0.72

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.10) − 1 = — (IC, example).